Ajax Therapeutics
Ajax was acquired by Eli Lilly

Ajax was acquired by Eli Lilly in April 2026. 

Domain
Healthcare
Status
IPO’d/​Acquired
Stage of Initial Investment
Series C
Initial Investment Year
2024